These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25350923)

  • 1. Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.
    Liu MM; Chen XY; Huang YQ; Feng P; Guo YL; Yang G; Chen Y
    J Med Chem; 2014 Nov; 57(22):9343-56. PubMed ID: 25350923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H; Wang K; Wan Q; Chen Y
    Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives.
    Wan Q; Deng Y; Huang Y; Yu Z; Wang C; Wang K; Dong J; Chen Y
    ChemistryOpen; 2020 Feb; 9(2):176-182. PubMed ID: 32025462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid of coumarin and phenylsulfonylfuroxan induces caspase-dependent apoptosis and cytoprotective autophagy in lung adenocarcinoma cells.
    Wang Q; Guo Y; Jiang S; Dong M; Kuerban K; Li J; Feng M; Chen Y; Ye L
    Phytomedicine; 2018 Jan; 39():160-167. PubMed ID: 29433677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives.
    Huang Y; Liu M; Meng L; Feng P; Guo Y; Ying M; Zhu X; Chen Y
    Steroids; 2015 Sep; 101():7-14. PubMed ID: 26004429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer.
    Han C; Huang Z; Zheng C; Wan L; Zhang L; Peng S; Ding K; Ji H; Tian J; Zhang Y
    J Med Chem; 2013 Jun; 56(11):4738-48. PubMed ID: 23668441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.
    Yu Z; Li M; Wang K; Gu Y; Guo S; Wang W; Ma Y; Liu H; Chen Y
    J Med Chem; 2022 Jul; 65(13):9328-9349. PubMed ID: 35737669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
    Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
    Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
    Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents.
    Guo Y; Wang Y; Li H; Wang K; Wan Q; Li J; Zhou Y; Chen Y
    ACS Med Chem Lett; 2018 May; 9(5):502-506. PubMed ID: 29795767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.
    Yamaguchi T; Kakefuda R; Tajima N; Sowa Y; Sakai T
    Int J Oncol; 2011 Jul; 39(1):23-31. PubMed ID: 21523318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.